NCT06495619

Brief Summary

The main goal of the clinical trial is to compare the short- and long-term outcomes of three 12-week interventions among outpatients with overweight/obesity and binge eating (BE):

  1. 1.treatment-as-usual for weight loss (TAU);
  2. 2.combined TAU and guided self-help for improving eating behaviors (TAU+GSH);
  3. 3.combined TAU, GSH, and biofeedback (TAU+GSH+BF). The primary outcomes will be self-reported reduction of days with objective BE episodes (OBEs).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 11, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

July 11, 2024

Status Verified

July 1, 2024

Enrollment Period

4 months

First QC Date

July 3, 2024

Last Update Submit

July 3, 2024

Conditions

Keywords

Binge EatingOverweightObesityGuided Self-HelpBiofeedback

Outcome Measures

Primary Outcomes (1)

  • objective BE episodes (OBEs)

    The primary outcomes will be self-reported reduction of days with objective BE episodes (OBEs)

    12-week follow-up-1 4-month follow-up-2 (after the end-of-treatment)

Secondary Outcomes (3)

  • psychological variables

    (T0) baseline; (T1)12-week follow-up-1; (T2) 4-month follow-up-2 (after the end-of-treatment)

  • physiological correlates of arousal

    (T0) baseline; (T1)12-week follow-up-1; (T2) 4-month follow-up-2 (after the end-of-treatment)

  • inflammatory biomarkers

    (T0) baseline; (T1)12-week follow-up-1; (T2) 4-month follow-up-2 (after the end-of-treatment)

Study Arms (3)

(1)TAU

ACTIVE COMPARATOR

treatment-as-usual for weight loss (TAU)

Behavioral: treatment-as-usual

(2)TAU+GSH

ACTIVE COMPARATOR

combined TAU and guided self-help for improving eating behaviors (TAU+GSH)

Behavioral: combined TAU and guided self-help

(3)TAU+GSH+BF

ACTIVE COMPARATOR

combined TAU, GSH, and biofeedback (TAU+GSH+BF)

Behavioral: combined TAU, GSH, and biofeedback

Interventions

life style modification intervention for weight loss

Also known as: TAU
(1)TAU

combined TAU and guided self-help for improving eating behaviors

Also known as: TAU+GSH
(2)TAU+GSH

combined TAU, GSH, and biofeedback for improving eating behaviors and interoceptive awareness and arousal regulation

Also known as: TAU+GSH+BF
(3)TAU+GSH+BF

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • de Zwaan M, Herpertz S, Zipfel S, Tuschen-Caffier B, Friederich HC, Schmidt F, Gefeller O, Mayr A, Lam T, Schade-Brittinger C, Hilbert A. INTERBED: internet-based guided self-help for overweight and obese patients with full or subsyndromal binge eating disorder. A multicenter randomized controlled trial. Trials. 2012 Nov 21;13:220. doi: 10.1186/1745-6215-13-220.

    PMID: 23171536BACKGROUND
  • DiMarco ID, Klein DA, Clark VL, Wilson GT. The use of motivational interviewing techniques to enhance the efficacy of guided self-help behavioral weight loss treatment. Eat Behav. 2009 Apr;10(2):134-6. doi: 10.1016/j.eatbeh.2009.02.001. Epub 2009 Feb 15.

    PMID: 19447358BACKGROUND
  • Mueller J, Richards R, Jones RA, Whittle F, Woolston J, Stubbings M, Sharp SJ, Griffin SJ, Bostock J, Hughes CA, Hill AJ, Boothby CE, Ahern AL. Supporting Weight Management during COVID-19 (SWiM-C): twelve-month follow-up of a randomised controlled trial of a web-based, ACT-based, guided self-help intervention. Int J Obes (Lond). 2023 Jan;47(1):51-59. doi: 10.1038/s41366-022-01232-x. Epub 2022 Nov 11.

    PMID: 36369513BACKGROUND
  • Varela C, Oda-Montecinos C, Andres A, Saldana C. Effectiveness of web-based feedback interventions for people with overweight and obesity: systematic review and network meta-analysis of randomized controlled trials. J Eat Disord. 2021 Jun 26;9(1):75. doi: 10.1186/s40337-021-00432-6.

    PMID: 34174949BACKGROUND
  • de Zwaan M, Herpertz S, Zipfel S, Svaldi J, Friederich HC, Schmidt F, Mayr A, Lam T, Schade-Brittinger C, Hilbert A. Effect of Internet-Based Guided Self-help vs Individual Face-to-Face Treatment on Full or Subsyndromal Binge Eating Disorder in Overweight or Obese Patients: The INTERBED Randomized Clinical Trial. JAMA Psychiatry. 2017 Oct 1;74(10):987-995. doi: 10.1001/jamapsychiatry.2017.2150.

    PMID: 28768334BACKGROUND
  • Frank DL, Khorshid L, Kiffer JF, Moravec CS, McKee MG. Biofeedback in medicine: who, when, why and how? Ment Health Fam Med. 2010 Jun;7(2):85-91.

    PMID: 22477926BACKGROUND

MeSH Terms

Conditions

BulimiaOverweightObesity

Interventions

GlutathioneBiofeedback, Psychology

Condition Hierarchy (Ancestors)

HyperphagiaSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Intervention Hierarchy (Ancestors)

OligopeptidesPeptidesAmino Acids, Peptides, and ProteinsMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Central Study Contacts

CHIARA CONTI, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 3, 2024

First Posted

July 11, 2024

Study Start

August 1, 2024

Primary Completion

December 1, 2024

Study Completion

June 30, 2025

Last Updated

July 11, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

The data sets generated during and/or analysed during the current study are available from the PI on reasonable request.